The Daily Biotech Pulse: Positive Readout For Kezar, AstraZeneca Stitches Oncology Partnership, D-Day For Merck's Triple Combo Antibiotic
04 Jun 2020 12:53 GMT
… 52-week Highs June 3)
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA)
BioMarin Pharmaceutical … ) sNDA for its triple combo antibiotic Recarbrio.
Related Link: Attention Biotech …
FDA Decisions: Keytruda/Padcev Combo Scores Second Nod, Checkpoint Hit with CRL
01 Jul 2023 02:39 GMT
… .7 billion acquisition of Arena Pharmaceuticals paid off in a … oral reformulation of the antibiotic metronidazole. With more than … a front-line oral antibiotic used commonly for parasitic … or prophylactic administration of antibiotics prior to treatment with …
Pfizer earnings and revenue top expectations despite Covid vaccine sales decline
02 May 2023 15:51 GMT
… of drugs like Sulperazon, an antibiotic for the treatment of urinary … colitis from the recently acquired Arena Pharmaceuticals.
Pfizer also said last year …
DelveInsight Highlights Major Advances, Transformative Therapies, and 80+ Leading Players Wheeling the Crohn's Disease Pipeline Landscape
17 Apr 2023 17:00 GMT
… such as aminosalicylates (sulfasalazine), antibiotics, or corticosteroids (budesonide), with … bowel syndrome companies, including Arena Pharmaceuticals, 4D Pharma, OrphoMed, … bowel syndrome companies, including Arena Pharmaceuticals, 4D Pharma, OrphoMed, …